Michael Lu represents clients in complex commercial and antitrust litigation in federal and state courts throughout the country. His practice focuses on class action defense, multi-jurisdictional litigation, and regulatory enforcement actions at both the trial and appellate levels on behalf of a diverse array of clients, including technology firms, life sciences companies, financial institutions, and state-owned entities. His practice also includes representing these clients in several non-U.S. jurisdictions, where he provides counseling across a broad spectrum of civil litigation matters.
Michael is actively involved in the Firm's pro bono work, and was recently a member of a White & Case trial team that secured a historic settlement on behalf of special needs schoolchildren in the city of Flint, Michigan in response to the city's lead water crisis.
Member of a global team overseeing and managing Meta Platforms' international civil litigation matters, with a focus on complex litigation in EMEA and Australia.
Defended Boehringer Ingelheim in class action multidistrict litigation arising from an alleged "reverse payment" scheme to delay generic competition to Boehringer's stroke prevention drug, Aggrenox, ultimately resulting in an appellate victory in the Second Circuit U.S. Court of Appeals that upheld the class action settlement.
Represented Pfizer in groundbreaking litigation challenging Johnson & Johnson's multifaceted scheme to maintain its monopoly over its blockbuster drug, Remicade, and foreclose biosimilar competition.
Member of a trial team that defended Allergan/Warner Chilcott in class action litigation alleging the drug maker's unlawful monopolization of the market for oral anti-inflammatory medications. The case resulted in a precedent-setting reversal of the trial court's class certification decision by the First Circuit U.S. Court of Appeals.
Member of a trial team that defended a leading global information services company in data breach litigation arising from a massive cyberattack that affected millions of customers' data.
Represented a major foreign state-owned financial institution in a regulatory enforcement action brought by the New York State Department of Financial Services related to alleged violations of New York's anti-money laundering laws.